Research Library

The case for increased opportunities for girls' education in the Arab world.

Data on revenues by payer type are used to identify the determinants of rising hospital prices in Texas between 2000 and 2007. By Vivian Ho, Jerome Dugan and Meei-Hsiang Ku-Goto.

Enhancement of American science, technology, engineering, and math education (STEM) at all levels, even early childhood, is a justifiable federal priority.

Energy experts from government, industry and academia investigate influences on oil and gas investments, as well as future directions for global commodity pricing.

Every patient with cancer or another life-threatening disease wants the most effective treatment, but drug prices have become staggering. What determines the escalating prices of cancer drugs?

For both generic and patented cancer drugs, the free-market economy has not worked well. Solutions are needed to maintain reasonable drug prices that allow for corporate profits and are affordable to patients and to the U.S. health care system.

Under this study, the Baker Institute will embark on a comprehensive study on the interaction of the oil investment cycle and the general business cycle, including consideration of how the global economy and patterns of industry capital investment are influenced by oil price shocks.

The causes and consequences of rising oil price over the past decade have been the subject of much debate. The role of speculation in financial markets has come increasingly under the microscope, with many economists arguing that in commodity markets such as oil, inventory adjustment should prevent speculative pressures from unduly influencing price. This paper investigates whether speculative pressures can exert an influence on the price of storable commodities, such as crude oil and natural gas.

A collaboration uniting the resources and expertise of Rice University's Baker Institute and the Organization of American States.

Allowing the producer-dominated market to set drug prices has spiraled the cost of cancer drugs out of control. Drug pricing can be reduced while preserving the profit-making incentive, by linking price to a true measure of quality: preservation and meaningful prolongation of life.